Navigation Links
Hospira Board Authorizes $1 Billion Share Repurchase Program
Date:4/25/2011

LAKE FOREST, Ill., April 25, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that its board of directors has authorized the repurchase of up to $1 billion of the company's common stock.

"This share repurchase program underscores our continued belief and optimism in Hospira's long-term growth prospects, as well as our commitment to return value to our shareholders," said F. Michael Ball, chief executive officer. "The share repurchase is one component of our planned uses of cash and capital structure, which we will update as scheduled when we announce our first-quarter 2011 results on April 26."

The multi-year program authorizes the company to repurchase common shares from time to time through the open market and through private transactions in compliance with securities regulations and other legal requirements. The size and timing of any purchases are at the discretion of company management, based on factors such as price, business and market conditions. The program does not have an expiration date.

The new authorization is the second share-repurchase authorization for the company. The first authorization, for $400 million of the company's common stock, was announced in February 2006 and recently completed.

For the three months ended Dec. 31, 2010, the company had approximately 170.1 million weighted average shares of common stock outstanding.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps impro
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
2. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
3. Hospira to Host Conference Call for First-Quarter 2011 Results
4. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
5. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
6. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
7. Hospira Announces U.S. Approval of Generic Docetaxel
8. Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
9. Hospira MedNet™ Portal Safety Software Benchmarking System Debuts at HIMSS
10. Hospira to Present at Upcoming Investor Conferences
11. Hospira Announces FDA Approval of Topotecan Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Cancer Therapeutics Market & Pipeline Insight 2014" report ... developed to prevent and eradicate the prevalence of cancer ... are confined to low specificity, safety and large number ... for a better solution. It has been discovered that ...
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2
... 19, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: ... product line has experienced double digit sales growth in ... is expected to generate an estimated 50 million yuan ... strength of the Company,s core product lines and rapid ...
... --  Terumo Cardiovascular Systems announced today that it has ... distribute the TigerPaw® System II, a left atrial appendage ... TigerPaw System II is indicated for occlusion of the ... other open cardiac procedures.  It is new to the ...
Cached Medicine Technology:China Health Resource Pharmaceutical Grade Gastrodia Product Line Expected to Contribute $8 Million in Revenue to 2011 Year End 2China Health Resource Pharmaceutical Grade Gastrodia Product Line Expected to Contribute $8 Million in Revenue to 2011 Year End 3Terumo Cardiovascular Systems Becomes Exclusive U.S. Distributor for TigerPaw® System II, Left Atrial Appendage Closure Device 2
(Date:8/30/2014)... 2014 United Theological Seminary is pleased to ... the Master of Theological Studies (MTS). , ... designed for students who wish to pursue further academic study ... to serve the Church and community. Previously, students needed to ... can attend classes from any location where there is an ...
(Date:8/30/2014)... Daily Gossip reveals in its recently published review ... created by Sarah Summer, who can perfectly understand what suffering ... new program actually had to deal with this disorder, too. ... to access it, in an all-natural holistic cure program. , ... effective cure for yeast infection. The author of this program ...
(Date:8/30/2014)... 30, 2014 The establishment and ... has been one of the main strategies of ... a positive impact around the world. , Architecturally ... top trained executives and trainers deliver L. Ron ... Vital statistics demonstrate that significant reduction in ...
(Date:8/30/2014)... New York, New York (PRWEB) August 30, 2014 ... and other incretin mimetic claims continue to move forward ... a statement issued by AstraZeneca PLC on July 31, ... have been named in 409 product liability claims that ... cancer. Court documents indicate that many of these claims ...
(Date:8/30/2014)... 30, 2014 Hastings and Hastings, a ... located throughout Arizona is pleased to report having saved ... specific example among many cases where Hastings and Hastings ... to retain a greater portion of their settlement or ... providing a positive solution for Arizona car accident victims ...
Breaking Medicine News(10 mins):Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Natural Cure for Yeast Infection Review Exposes New Natural Treatment 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2
... lags behind in curbing the maternal and infant mortality ... childbirth complications. ,"Maternal health is the foundation ... function organised here Monday on the eve of Safe ... several MPs and Delhi Health Minister Yoganand Shastri, Hota ...
... due at least in part to an attraction between ... stop eating, and a protein more recently// associated with ... not only binds to leptin but its hold impairs ... may help explain why obese people have so much ...
... Sunday saw yet another nationwide polio immunization drive. However, ... upon officers in Western Uttar Pradesh// whose laxity he ... ,Several officers have been punished in this ... officers according to the Health Minister. ...
... revealed that infants of habitually snoring parents are also ... addition researchers have also found that children with atopy ... snoring. ,Sleep-disordered breathing among children had been ... disorders and heart disease. ,When airflow becomes ...
... requiring work permit to be made mandatory for non-European doctors, ... Service// (NHS), has brought about nervousness among the Indian doctors. ... doctors already working there are expected to be affected in ... assignment. With this rule it would become almost impossible for ...
... Jude Children's Research Hospital in Memphis have found that ... in their parents and vice versa.// Their study, which ... a peer-reviewed journal of the American Cancer Society, says ... health related quality of life (HRQL) as their kid. ...
Cached Medicine News:Health News:Maternal Mortality Rate On Rise In India 2Health News:Researchers Identify The Cause To Obesity 2Health News:Researchers Identify The Cause To Obesity 3Health News:Snoring Runs in the Family 2
... Akers, our ultimate goal is to provide ... and immediate treatment. Each year millions of ... die from late detection or undetected disease ... cripple nations., ,By developing, manufacturing and marketing ...
... BD Macro-Vue RPR (Rapid Plasma Reagin) ... Tests are nontreponemal testing procedures for ... in A Manual of Tests for ... manual are the most widely used ...
Rapid Plasma Reagin (RPR) set is a non-treponemal flocculation test that is,used for the qualitative and semi-quantitative determination of reagin,antibodies in serum or plasma from persons with syph...
... assurance reagent in assays detecting IgG and IgM ... IgM), IgG and IgM antibodies to rubella virus ... antibodies to cytomegalovirus (CMV IgG and IgM), and ... types 1 and 2 (HSV-1 IgG, HSV-1 IgM, ...
Medicine Products: